Literature DB >> 18766422

Rectal and pouch recurrences after surgical treatment for familial adenomatous polyposis.

Fabio Guilherme Campos1, Antonio Rocco Imperiale, Víctor Edmond Seid, Rodrigo Oliva Perez, Afonso Henrique da Silva e Sousa, Desidério Roberto Kiss, Angelita Habr-Gama, Ivan Cecconello.   

Abstract

BACKGROUND: Familial adenomatous polyposis (FAP) is a genetic disease characterized by multiple adenomatous colorectal polyps and different extracolonic manifestations (ECM). The present work is aimed to analyze the outcome after surgical treatment regarding complications and cancer recurrence.
METHODS: Charts from patients treated between 1977 and 2006 were retrospectively analyzed. Clinical and endoscopic data, results of treatment, pathological reports and information about recurrence were collected.
RESULTS: Eighty-eight patients (41 men [46.6%] and 47 women [53.4%]) were assisted. At diagnosis, associated colorectal cancer (CRC) was detected in 53 patients (60.2%), whose average age was higher than those without CRC (40.0 vs. 29.5 years). At colonoscopy, polyposis was classified as attenuated in 12 patients (14.3%). Surgical treatment consisted in total proctocolectomy with ileostomy (PCI, 15 [17.4%]), restorative proctocolectomy (RPC, 27 [31.4%]), total colectomy with ileal-rectum anastomosis (IRA, 42 [48.8%]), palliative segmental resection (1 [1.2%]) and internal bypass (1 [1.2%]). Two patients were not operated on due to religious reasons and advanced disease. Complications occurred in 25 patients (29.0%), more commonly after RPC (48.1%). There was no operative mortality. Local or distant metastases were detected in six (11.3%) patients with CRC treated to cure. During the follow-up of 36 IRA, cancer developed in the rectal cuff in six patients (16.6%), whose average age was higher than in patients without rectal recurrence (45.8 vs. 36.6 years). Five of them have had colonic cancer in the resected specimen. Among the 26 patients followed after RPC, cancer in the ileal pouch developed in 1 (3.8%).
CONCLUSIONS: (1) Within the present series, FAP patients presented a high incidence of associated CRC and diagnosis was generally established after the third decade of life; (2) operative complications occurred in about one third of the patients, being more frequent after the confection of an ileal reservoir; (3) rectal cancer after IRA was detected in 16.6% of patients and it was associated with greater age and previous colonic carcinoma; (4) both continuous and long-term surveillance of the rectal stump and ileal pouch are necessary during follow-up.

Entities:  

Mesh:

Year:  2008        PMID: 18766422     DOI: 10.1007/s11605-008-0606-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  50 in total

1.  Rectal cancer risk in older patients with familial adenomatous polyposis and an ileorectal anastomosis: a cause for concern.

Authors:  K P Nugent; R K Phillips
Journal:  Br J Surg       Date:  1992-11       Impact factor: 6.939

Review 2.  Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous polyposis.

Authors:  O Aziz; T Athanasiou; V W Fazio; R J Nicholls; A W Darzi; J Church; R K S Phillips; P P Tekkis
Journal:  Br J Surg       Date:  2006-04       Impact factor: 6.939

3.  Risk factors for rectal cancer morbidity and mortality in patients with familial adenomatous polyposis after colectomy and ileorectal anastomosis.

Authors:  J A Björk; H I Akerbrant; L E Iselius; R W Hultcrantz
Journal:  Dis Colon Rectum       Date:  2000-12       Impact factor: 4.585

Review 4.  Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature.

Authors:  M H Nieuwenhuis; H F A Vasen
Journal:  Crit Rev Oncol Hematol       Date:  2006-10-24       Impact factor: 6.312

5.  Proctocolectomy without ileostomy for ulcerative colitis.

Authors:  A G Parks; R J Nicholls
Journal:  Br Med J       Date:  1978-07-08

6.  Adenocarcinoma arising in "J" pouch after total proctocolectomy for familial polyposis coli.

Authors:  V M Palkar; L J deSouza; P Jagannath; K N Naresh
Journal:  Indian J Cancer       Date:  1997-03       Impact factor: 1.224

7.  Long-term follow-up after colectomy and ileorectal anastomosis in familial adenomatous polyposis coli. Is there still a place for the procedure?

Authors:  J F Slors; F C den Hartog Jager; J W Trum; C W Taat; W H Brummelkamp
Journal:  Hepatogastroenterology       Date:  1989-04

8.  Female fecundity before and after operation for familial adenomatous polyposis.

Authors:  K Ø Olsen; S Juul; S Bülow; H J Järvinen; A Bakka; J Björk; T Oresland; S Laurberg
Journal:  Br J Surg       Date:  2003-02       Impact factor: 6.939

9.  Factors affecting the risk of rectal cancer following rectum-preserving surgery in patients with familial adenomatous polyposis.

Authors:  T Iwama; Y Mishima
Journal:  Dis Colon Rectum       Date:  1994-10       Impact factor: 4.585

10.  Age-related analysis of functional outcome and quality of life after restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis.

Authors:  Ayhan B Erkek; James M Church; Feza H Remzi
Journal:  J Gastroenterol Hepatol       Date:  2007-05       Impact factor: 4.029

View more
  9 in total

Review 1.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

2.  Evaluating causes of death in familial adenomatous polyposis.

Authors:  Fábio Guilherme C M de Campos; Rodrigo Oliva Perez; Antônio Rocco Imperiale; Víctor Edmond Seid; Sérgio Carlos Nahas; Ivan Cecconello
Journal:  J Gastrointest Surg       Date:  2010-07-30       Impact factor: 3.452

3.  Laparoscopic colectomy and restorative proctocolectomy for familial adenomatous polyposis.

Authors:  Marco Vitellaro; Giuliano Bonfanti; Paola Sala; Elia Poiasina; Marta Barisella; Stefano Signoroni; Andrea Mancini; Lucio Bertario
Journal:  Surg Endosc       Date:  2010-12-07       Impact factor: 4.584

Review 4.  Surgical treatment of familial adenomatous polyposis: dilemmas and current recommendations.

Authors:  Fábio Guilherme Campos
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

5.  Adenocarcinomas After Prophylactic Surgery For Familial Adenomatous Polyposis.

Authors:  Joan C Smith; Michael W Schäffer; Billy R Ballard; Duane T Smoot; Alan J Herline; Samuel E Adunyah; Amosy E M'Koma
Journal:  J Cancer Ther       Date:  2013

6.  Prevalence and risk factors for adenomas in the ileal pouch and the afferent loop after restorative proctocolectomy for patients with familial adenomatous polyposis.

Authors:  Elise Pommaret; Ariane Vienne; Jérémie H Lefevre; Philippe Sogni; Christian Florent; Benoît Desaint; Yann Parc
Journal:  Surg Endosc       Date:  2013-05-01       Impact factor: 4.584

Review 7.  Incidence and Risk Factors of Cancer in the Anal Transitional Zone and Ileal Pouch following Surgery for Ulcerative Colitis and Familial Adenomatous Polyposis.

Authors:  Guillaume Le Cosquer; Etienne Buscail; Cyrielle Gilletta; Céline Deraison; Jean-Pierre Duffas; Barbara Bournet; Géraud Tuyeras; Nathalie Vergnolle; Louis Buscail
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

8.  Metastatic Rectal Adenocarcinoma in Familial Adenomatous Polyposis: A Case of Socioeconomic Factors Influencing Surveillance Endoscopy.

Authors:  Paul Guzik; Harold J Duarte; Nour A Parsa
Journal:  Cureus       Date:  2022-08-30

9.  Prevalence and Management of Cancer of the Rectal Stump after Total Colectomy and Rectal Sparing in Patients with Familial Polyposis: Results from a Registry-Based Study.

Authors:  Gaia Colletti; Chiara Maura Ciniselli; Stefano Signoroni; Ivana Maria Francesca Cocco; Andrea Magarotto; Maria Teresa Ricci; Clorinda Brignola; Clara Bagatin; Laura Cattaneo; Andrea Mancini; Federica Cavalcoli; Massimo Milione; Paolo Verderio; Marco Vitellaro
Journal:  Cancers (Basel)       Date:  2022-01-08       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.